Stanford University

Return to Grants

Total Awards:
173
Award Value:
$525,282,107
Institution type:
Not for profit
Short Name:
Stanford

Awards to the Institution

Program Type Investigator Grant Title Award Value
Manufacturing Network Grant Steven Feldman Laboratory for Cell and Gene Medicine: A partner in the California Cell and Gene Therapy Manufacturing Network $2,000,000
Foundation – Discovery Stage Research Projects Dr. Marius Wernig MD, PhD Developing a microglia replacement therapy $1,378,365
Research Training Grant Dr. Tushar Desai CIRM Scholar Training Program $5,347,815
Discovery Research Projects Dr. Albert J Wong Identifying HLA Class I Restricted Peptides That Induce CD8+ T Cells Against SARS-CoV-2 $249,999
Discovery Research Projects Dr. Helen M Blau Application of PGE2/BPV, a muscle stem cell targeting therapeutic, to the treatment of COVID-19 associated diaphragm atrophy $149,996
Progression Award – Discovery Stage Research Projects Dr. Helen M Blau Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
Progression Award – Discovery Stage Research Projects Professor Hiromitsu Nakauchi Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Alpha Stem Cell Clinics Network Expansion Dr. Matthew H Porteus The Stanford Alpha Stem Cell Clinic $6,920,810
Quest – Discovery Stage Research Projects Dr. Robert Negrin MD Orthogonal IL2 Receptor Transduced Regulatory T Cells for Clinical Application $1,920,652
Quest – Discovery Stage Research Projects Dr. Michael F Clarke Developing a breast cancer stem cell drug $2,053,727
Quest – Discovery Stage Research Projects Dr. Judith A Shizuru Targeted Immunotherapy-Based Blood Stem Cell Transplantation $1,341,910
Quest – Discovery Stage Research Projects Ansuman Satpathy Preclinical development of an exhaustion-resistant CAR-T stem cell for cancer immunotherapy $1,420,200
Quest – Discovery Stage Research Projects Dr. Bertha Chen iPSC-derived smooth muscle cell progenitor conditioned medium for treatment of pelvic organ prolapse $1,420,200
Quest – Discovery Stage Research Projects Dr. Sarah C Heilshorn Injectable, autologous iPSC-based therapy for spinal cord injury $789,000
Quest – Discovery Stage Research Projects Dr. Stanley Qi A novel hybrid CRISPR tool for gene network perturbation and hiPSC engineering $704,661
Quest – Discovery Stage Research Projects Dr. Marius Wernig MD, PhD A universally applicable skin sheet for Dystrophic Epidermolysis Bullosa via next-generation gene editing, iPS cell technology and tissue engineering $1,229,040
Quest – Discovery Stage Research Projects Dr. Phillip Chung-Ming Yang Hypoxia-specific Production of Exosomes from iPSC-derivatives for Myocardial Repair $1,418,023
Quest – Discovery Stage Research Projects Kathleen M Sakamoto Small Molecules to inhibit Nemo-like Kinase for Treatment of Diamond Blackfan Anemia $848,098
Quest – Discovery Stage Research Projects Alan G Cheng Modulation of the Wnt pathway to restore inner ear function $1,389,416
Quest – Discovery Stage Research Projects Dr. Katja Weinacht Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome $1,251,720
Quest – Discovery Stage Research Projects Dr. Philip Arden Beachy PhD Pluripotent stem cell-derived bladder epithelial progenitors for definitive cell replacement therapy of bladder cancer $1,265,436
Quest – Discovery Stage Research Projects Dr. Kyle M Loh Towards hepatocyte cell replacement therapy: developing a renewable source of human hepatocytes from pluripotent stem cells $1,968,456
Quest – Discovery Stage Research Projects Dr. Helen M Blau Stimulating endogenous muscle stem cells to counter muscle atrophy $2,198,687
Quest – Discovery Stage Research Projects Dr. Mark Mercola Multipotent Cardiovascular Progenitor Regeneration of the Myocardium after MI $1,809,234
Quest – Discovery Stage Research Projects Dr. Matthew H Porteus Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells $1,968,456
Quest – Discovery Stage Research Projects Dr. Roel Nusse Preclinical development of human hepatocyte progenitor cells for cell therapy $1,651,211
Quest – Discovery Stage Research Projects Dr. Rosa Bacchetta GENE EDITING FOR FOXP3 IN HUMAN HSC $984,228
Quest – Discovery Stage Research Projects Professor Hiromitsu Nakauchi Novel Rejuvenated T Cell Immunotherapy for Lung Cancer $1,968,456
Inception – Discovery Stage Research Projects Professor Hiromitsu Nakauchi Optimizing self-renewal signaling kinetics to stabilize ex vivo hematopoietic stem cell expansion $210,906
Inception – Discovery Stage Research Projects Guillem Pratx Novel metabolic labeling method for tracking stem cells to irradiated salivary glands using PET $229,227
Inception – Discovery Stage Research Projects Dr. Helen M Blau Prodrug innovation to target muscle stem cells and enhance muscle regeneration $235,834
Inception – Discovery Stage Research Projects Jeffrey L Goldberg Embryonic Stem Cells for Corneal Endothelial Degeneration $235,836
Inception – Discovery Stage Research Projects Dr. Philip Arden Beachy PhD Curing bladder cancer by replacing corrupted urothelium with differentiated hES cells $210,906
Inception – Discovery Stage Research Projects Dr. Bertha Chen Autologous iPSC-based therapy for radiation induced bladder injury $235,836
Inception – Discovery Stage Research Projects Dr. Phillip Chung-Ming Yang Activation of patient-specific endogenous myocardial repair through the exosomes generated from the hypoxic iPSC-derived cardiomyocytes (iCMs). $234,619
Tool Translational Research Projects Dr. Joseph C. Wu A Novel, Robust and Comprehensive Predictive Tool Using Human Disease-Specific Induced Pluripotent Stem Cells for Preclinical Drug Screening $975,000
Therapeutic Translational Research Projects Walter Park Enhanced Autologous Pancreatic Islet Transplantation and Survival for Diabetes Mellitus Therapy $6,054,165
Therapeutic Translational Research Projects Dr. Theodore Leng NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration $4,235,758
Therapeutic Translational Research Projects Dr. Bertha Chen Autologous iPSC-derived smooth muscle cell therapy for treatment of urinary incontinence $5,977,155
Therapeutic Translational Research Projects Dr. Anthony E. Oro DEBCT: Genetically Corrected, Induced Pluripotent Cell-Derived Epithelial Sheets for Definitive Treatment of Dystrophic Epidermolysis Bullosa $5,107,353
Therapeutic Translational Research Projects Dr. Albert J Wong 2nd Generation Vaccine for the Treatment of Glioblastoma $2,929,889
SPARK Paul J. Utz Stem Cell and Regenerative Medicine- High School Summer Research Internship $495,060
SPARK Paul J. Utz Stem Cell and Regenerative Medicine- Summer Research Internship $350,482
Conference II Dr. Ngan F Huang Bay Area Stanford Regenerative Medicine Conference for Students—A TERMIS-AM Ambassador’s Conference $3,320
Conference II Dr. Everett H. Meyer Cellular Immune Tolerance Symposium $31,225
Conference II Dr. Joseph C. Wu Stanford Drug Discovery Symposium 2023 $50,000
Conference II Dr. Joseph C. Wu Stanford Drug Discovery Symposium 2022 $29,408
Conference II Dr. Joseph C. Wu 2018 Stanford Drug Discovery and Stem Cell Technology Conference $15,000
Conference II Dr. Samuel Strober Third International Workshop on Clinical Tolerance $29,500
Conference II Dr. Joseph C. Wu 2017 Stanford Drug Discovery and Stem Cell Technology Conference $2,359
Conference II Dr. Joseph C. Wu Drug Discovery & Stem Cell Models for Cardiovascular Disease Conference $7,500
Clinical Trial Stage Projects Dr. Reena Parada Thomas Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme $11,999,991
Clinical Trial Stage Projects Anusha Kalbasi Stem-Derived IL13Ra2 Chimeric Antigen Receptor T cells for Patients with Melanoma and Advanced Solid Tumors $10,211,085
Clinical Trial Stage Projects Dr. Matthew H Porteus Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients $10,642,420
Clinical Trial Stage Projects Alice Bertaina Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant $11,998,188
Clinical Trial Stage Projects Dr. Rosa Bacchetta Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome $11,999,179
Clinical Trial Stage Projects Dr. Joseph C. Wu A Phase I, Pilot Study of Human Embryonic Stem Cell-Derived Cardiomyocytes in PaTients with ChrOnic Ischemic Left VentRicular Dysfunction (HECTOR) $6,987,507
Clinical Trial Stage Projects Crystal Mackall Phase 1 Clinical Trial of Autologous GD2 Chimeric Antigen Receptor T Cells for Diffuse Intrinsic Pontine Gliomas and Spinal Diffuse Midline Glioma $11,998,310
Clinical Trial Stage Projects Dr. Matthew H Porteus Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies. $10,563,822
Clinical Trial Stage Projects Dr. Gary Steinberg Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects with Chronic Ischemic Subcortical Stroke $11,998,988
Clinical Trial Stage Projects Dr. Judith A Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $1,113,487
Clinical Trial Stage Projects Dr. Everett H. Meyer Induction of Tolerance by Combinatorial Therapy w/ Donor Stem Cells and Expanded Recipient Treg cells in HLA-mismatched Kidney Transplant Recipients $11,955,585
Clinical Trial Stage Projects Dr. David B. Miklos Phase 1 Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Adults with Recurrent or Refractory B Cell Malignancies $11,034,982
Clinical Trial Stage Projects Dr Robert Lowsky Induction of Tolerance to Combined Kidney and Hematopoietic Progenitor Cell Transplants from HLA Haplotype Matched Living Donors $6,653,266
Late Stage Preclinical Projects Natalia Gomez-Ospina Genome Editing of Autologous Hematopoietic Stem Cells to Treat Severe Mucopolysaccharidosis type 1 (Hurler Syndrome) $5,444,353
Late Stage Preclinical Projects Dr. Rosa Bacchetta IND-enabling activities for a Phase 1 Study of Autologous CD4LVFOXP3 T Cells in Subjects with IPEX Syndrome $5,002,496
Late Stage Preclinical Projects Dr. Matthew H Porteus Genome Editing of Autologous Hematopoietic Stem Cells to Treat Sickle Cell Disease $4,849,363
Late Stage Preclinical Projects Dr. Gary Steinberg Intraparenchymal NR1 Stem Cell Therapy for Chronic Subcortical Ischemic Stroke $5,300,000
Preclinical Development Awards Dr. Matthew H Porteus Pre-clinical development of gene correction therapy of hematopoietic stem cells for SCID-X1 $874,877
Tools and Technologies III Sarah Heilshorn Injectable Hydrogels for the Delivery, Maturation, and Engraftment of Clinically Relevant Numbers of Human Induced Pluripotent Stem Cell-Derived Neural Progenitors to the Central Nervous System $1,347,767
Tools and Technologies III Dr. James C. Dunn Dr. Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $772,098
Tools and Technologies III Dr. Fan Yang PhD Injectable Macroporous Matrices to Enhance Stem Cell Engraftment and Survival $1,434,235
Tools and Technologies III Dr. Joseph C. Wu Macaca mulatta as advanced model for predictive preclinical testing of engineered cardiac autografts and allografts $1,689,744
Tools and Technologies III Dr. Anthony E. Oro A Chromatin Context Tool for Predicting iPS Lineage Predisposition and Tissue Graftability $1,391,125
Tools and Technologies III Dr. Irving L Weissman MD Identification and isolation of transplantable human hematopoietic stem cells from pluripotent cell lines; two steps from primitive hematopoiesis to transplantable definitive cells, and non-toxic conditioning of hosts for hematopoeitic stem cell transp… $1,271,952
Conference Dr. Joseph C. Wu Cardiovascular Tissue Engineering Symposium $25,000
Conference Hank Greely Stem Cell Policy: Understanding the Scientific and Legal Challenges Ahead $5,838
Conference Dr. Thomas A. Rando MD, PhD Keystone Symposia, ‘The Life of a Stem Cell: From Birth to Death’ $50,000
Conference Dr. Joseph C. Wu Cardiovascular Regenerative Medicine Symposium $9,000
Conference Dr. Fan Yang PhD 2014 Materials Research Society (MRS) Spring Meeting: Symposium Y: Biomaterials for Biomolecule Delivery and Understanding Cell-Niche Interactions $10,000
Conference Dr. Thomas A. Rando Third Annual Symposium on Regenerative Rehabilitation $20,000
Conference Dr. Julian Sage 3rd International RB conference $10,000
Genomics Centers of Excellence Awards (R) Dr. Michael P Snyder PhD Center of Excellence for Stem Cell Genomics – Stanford $22,787,914
Disease Team Planning Dr. Robert Robbins {REDACTED} Cardiovascular Regenerative Team $25,119
Disease Team Planning Dr. Thomas A. Rando MD, PhD Stem Cell Therapy for Muscular Dystrophy $0
Major Facilities Dr. John L. Hennessy Stanford SIM1 Building $43,578,000
Basic Biology V Dr. Helen M Blau Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
Basic Biology V Dr. Marius Wernig MD, PhD Mechanisms of human induced neuronal cell reprogramming $1,178,370
Basic Biology V Dr. Gary Steinberg Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
Basic Biology V Xinnan Wang Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
Disease Team Therapy Development III Dr. Irving L Weissman MD Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $6,505,568
Patent Assistance Fund Awards Katharine Ku Funding for Patent Applications for CIRM-funded Inventions out of Stanford University $3,525
Early Translational IV Dr. Michele Calos Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
Tissue Collection for Disease Modeling Dr. Joseph C. Wu Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases $1,291,832
Tissue Collection for Disease Modeling Joachim Franz Hallmayer Induced pluripotent stem cells from children with autism spectrum disorders $530,265
New Faculty Physician Scientist Alan G Cheng Enhancing hair cell regeneration in mouse and human inner ear $3,088,525
New Faculty Physician Scientist Michelle Monje White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” $2,800,526
Creativity Awards Paul J. Utz SIMR Program: Stem Cell & Developmental Biology Research Internships $340,611
Basic Biology IV Dr. Gerald R. Crabtree Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch $1,392,150
Basic Biology IV Dr. Roel Nusse Asymmetric stem cell division oriented by a local self-renewing signal $1,038,600
Basic Biology IV Dr. Howard Y. Chang Long noncoding RNAs for pluripotency and cell fate commitment $1,386,627
Basic Biology IV Ben A Barres Phenotyping Human Astrocytes in Health and Disease $0
Basic Biology IV Alexander Robert Dunn Role of mechanical signaling in stem cell self-renewal and differentiation $1,062,998
Basic Biology IV Dr. Anne Brunet Energy metabolism and aging pathways in human stem cell reprogramming and differentiation $1,414,044
Basic Biology IV Michael Cleary Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells $1,244,455
Basic Biology IV Michelle Monje Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain $1,264,248
Disease Team Therapy Development – Research Dr. Joseph C. Wu Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $19,060,330
Disease Team Therapy Development – Research Dr. Judith A Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $18,990,683
Early Translational III Dr. Joseph C. Wu Heart Repair with Human Tissue Engineered Myocardium $4,395,080
Early Translational III Professor Helen M. Blau PhD Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,283
Early Translational III Dr. Bertha Chen Autologous iPSC Therapy for Urinary Incontinence $4,715,738
Training Grant I-1 Michael T. Longaker M.D. Stanford CIRM Training Program $3,035,282
Disease Team Therapy Planning I Dr. Albert J Wong Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Disease Team Therapy Planning I Dr. Judith A Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
Disease Team Therapy Planning I Dr. Robert Robbins Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $73,030
Research Training II Dr. Theo D. Palmer PhD Stanford CIRM Training Program $7,017,629
Basic Biology III Dr. Aaron J Hsueh Correlated time-lapse imaging and single cell molecular analysis of human embryo development $1,259,733
Basic Biology III Sean M. Wu Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells $1,260,537
Basic Biology III Dr. Michael F Clarke USP16 controls stem cell number: implications for Down Syndrome $1,263,826
Basic Biology III Dr. Joanna Wysocka PhD Enhancer-mediated gene regulation during early human embryonic development $1,420,618
Tools and Technologies II Dr. Marius Wernig MD, PhD Cellular tools to study brain diseases affecting synaptic transmission $1,664,382
Tools and Technologies II Dr. Irving L Weissman MD Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,463,814
Tools and Technologies II Dr. Brian K. Rutt Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,833,348
Tools and Technologies II Dr. Sarah C Heilshorn Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels $600,695
Tools and Technologies II Dr. Theo D. Palmer PhD Development of small molecule screens for autism using patient-derived iPS cells $1,797,606
Tools and Technologies II Dr. Michele Calos Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,592,897
Early Translational II Dr. Michele Calos Stem Cell Therapy for Duchenne Muscular Dystrophy $2,267,261
Research Leadership Professor Hiromitsu Nakauchi Generation of functional cells and organs from iPSCs $5,426,135
New Faculty I Dr. Anne Brunet Molecular mechanisms involved in adult neural stem cell maintenance $2,348,435
New Faculty I Dr. Joanna Wysocka PhD Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,373,903
New Faculty I Karl Deisseroth Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $2,424,209
New Faculty I Dr. Howard Y. Chang Noncoding RNAs in Cell Fate Determination $2,985,894
Early Translational I Dr. Jill Helms Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,464,126
Transplantation Immunology Dr. Ken Weinberg Engineered immune tolerance by Stem Cell-derived thymic regeneration $1,271,729
Transplantation Immunology Dr. Robert Negrin MD Regulatory T cell induced tolerance to ESC transplantation $1,382,658
Transplantation Immunology Professor Christopher H. Contag Engineering Embryonic Stem Cell Allografts for Operational Tolerance $1,411,338
Transplantation Immunology Dr. Judith A Shizuru Purified allogeneic hematopoietic stem cells as a platform for tolerance induction $1,233,275
Tools and Technologies I Professor Helen M. Blau PhD Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells $949,608
Shared Labs Dr. Renee Reijo Pera PhD The Stanford University Center for Human Embryonic Stem Cell Research and Education $2,439,590
Shared Labs Prof Vittorio Sebastiano The Stanford University Center for Human Embryonic Stem Cell Research and Education $3,434,600
New Faculty II Dr. Ching-Pin Chang VEGF signaling in adventitial stem cells in vascular physiology and disease $3,005,695
New Cell Lines Dr. Renee Reijo Pera PhD Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype $1,409,243
New Cell Lines Michael T. Longaker M.D. Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts $1,406,636
New Cell Lines Dr. Julie Baker Derivation of hESC Lines with Disease Lesions $1,404,725
New Cell Lines Dr. Michele Calos Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses $1,406,875
Comprehensive Grant Dr. Irving L Weissman MD Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells $2,471,386
Comprehensive Grant Dr. Stefan Heller Generation of inner ear sensory cells from human ES cells toward a cure for deafness $2,330,371
Comprehensive Grant Dr. Roel Nusse Guiding the developmental program of human embryonic stem cells by isolated Wnt factors $1,710,462
Comprehensive Grant Dr. Renee Reijo Pera PhD Human oocyte development for genetic, pharmacological and reprogramming applications $2,298,411
Comprehensive Grant Dr. Christopher K. Zarins Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells $2,454,490
Comprehensive Grant Dr. Theo D. Palmer PhD Immunology of neural stem cell fate and function $2,396,000
Comprehensive Grant Dr. Julie Baker Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cells $2,518,303
SEED Grant Dr. Aaron J Hsueh Patient-specific cells with nuclear transfer $629,653
SEED Grant Dr. Joseph C. Wu In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity $623,634
SEED Grant Dr. Ken Weinberg Embryonic stem cell-derived thymic epithelial cells $628,793
SEED Grant Dr. Mark Kay Dr. Novel vectors for gene transfer into human ES cells $574,737
SEED Grant Dr. Susan K McConnell Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease $607,363
SEED Grant Dr. Phillip Chung-Ming Yang In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction $629,952
SEED Grant Dr. Joanna Wysocka PhD Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency $629,952
SEED Grant Dr. Thomas Wandless Reprogramming Differentiated Human Cells to a Pluripotent State $380,005
SEED Grant Dr. John P. Cooke EC regeneration in cerebrovascular ischemia: role of NO $476,995
SEED Grant Dr. Julien Sage Functions of RB family proteins in human embryonic stem cells $498,609
SEED Grant Dr. Calvin Jay Kuo Differentiation of Human Embryonic Stem Cells to Intestinal Fates $554,176
SEED Grant Dr. Krishna Shenoy Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium $572,891
Basic Biology II Professor Garry P Nolan Kinase signaling analysis of iPS cell reprogramming and differentiation $1,343,100
Basic Biology II Dr. Aaron J Hsueh Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation $1,309,018
Basic Biology II Dr. Steven Edward Artandi Self-renewal and senescence in iPS cells derived from patients with a stem cell disease $931,285
Disease Team Research I Dr. Gary Steinberg Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke $17,244,851
Disease Team Research I Dr. Alfred T Lane iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa $11,039,208
Disease Team Research I Dr. Irving L Weissman MD Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells $18,759,276
Basic Biology I Dr. Julian Sage The retinoblastoma (RB) gene family in cellular reprogramming $1,357,085
Basic Biology I Dr. Susan K McConnell Identification and characterization of human ES-derived DA neuronal subtypes $1,404,853
Basic Biology I Dr. Helen M Blau Molecular Mechanisms of Reprogramming towards Pluripotency $1,408,332
Total:
$525,282,107.24